$LH LABORATORY CORP OF AMERICA HOLDINGS Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in LABORATORY CORP OF AMERICA HOLDINGS. Find out how many shares they currently own, their value and whether they buy or sell their shares.
LABORATORY CORP OF AMERICA HOLDINGS Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
ANDERSON KERRII B | Director | 19,880 | 2,581,617 | Feb 08 2021 | |||
ANDERSON KERRII B | Director | 4,143 | 538,010 | May 09 2008 | |||
BELINGARD JEAN LUC | Director | 18,169 | 2,359,426 | May 05 2021 | |||
BELINGARD JEAN LUC | Director | 22,613 | 2,936,524 | May 20 2008 | |||
BELINGARD JEAN-LUC | Director | 29,426 | 3,821,260 | Feb 12 2015 | |||
BERBERIAN LANCE | EVP, CIO & CTO | 15,265 | 1,982,313 | Mar 30 2021 | |||
Boyle James T. Jr. | EVP,CEO of LabCorp Diagnostics | 23,454 | 3,045,736 | Apr 01 2016 | |||
Brecher Mark E | CMO, LabCorp Diagnostics | 5,511 | 715,658 | Apr 01 2015 | |||
Caveney Brian J | EVP, President of Diagnostics | 9,080 | 1,179,129 | Mar 30 2021 | |||
COLES N ANTHONY | Director | 2,584 | 335,558 | Feb 19 2013 | |||
Conrad Andrew J | EVP, Chief Scientific Officer | 26,541 | 3,446,614 | Feb 11 2011 | |||
Cook Woodrow L | EVP, Eastern Operations | 12,535 | 1,627,795 | Nov 01 2007 | |||
Davis Jeffrey A. | Director | 1,159 | 150,508 | Feb 08 2021 | |||
Dodson Edward T | Principal Accounting Officer | 15,442 | 2,005,298 | Apr 03 2019 | |||
EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 28,887 | 3,751,266 | Feb 14 2019 | |||
EBERTS F SAMUEL III | Chief Legal Officer, Secretary | 20,099 | 2,610,056 | Feb 17 2015 | |||
EISENBERG GLENN A | Chief Financial Officer, EVP | 41,028 | 5,327,896 | Mar 30 2021 | |||
EISENBERG GLENN A | Chief Financial Officer, EVP | 2,148 | 278,939 | Feb 17 2015 | |||
ELINGBURG WESLEY R | EVP, Chief Financial Officer | 99,103 | 12,869,516 | Mar 18 2004 | |||
ELINGBURG WESLEY R | EVP & Chief Financial Officer | 56,244 | 7,303,846 | May 06 2005 | |||
Fonseca Lidia | Chief Information Officer | 9,087 | 1,180,038 | Apr 01 2013 | |||
Gary M. Huff | CEO, LabCorp Diagnostics | 1,919 | 249,201 | Sep 06 2018 | |||
Gilliland Dwight Gary | Director | 6,752 | 876,815 | Feb 08 2021 | |||
HAAS WILLIAM | EVP, Sales & Marketing | 10,000 | 1,298,600 | Feb 24 2004 | |||
HAAS WILLIAM | EVP, Esoterix Business | 44,249 | 5,746,175 | May 09 2008 | |||
HARDISON DON M | EVP, COO | 18,848 | 2,447,601 | May 09 2008 | |||
HARDISON DON M | EVP | 19,928 | 2,587,850 | Jan 15 2010 | |||
Hayes William B | Chief Financial Officer, EVP | 18,804 | 2,441,887 | May 09 2008 | |||
Hayes William B | Chief Financial Officer, EVP | 19,400 | 2,519,284 | Jun 10 2014 | |||
HERRING JOSEPH L | CEO of Covance Drug Division | 10,404 | 1,351,063 | Aug 04 2015 | |||
KING DAVID P | Director | 312,554 | 40,588,262 | May 07 2020 | |||
KING DAVID P | President & CEO | 67,772 | 8,800,872 | May 30 2008 | |||
KING DAVID P | President & CEO | 65,058 | 8,448,432 | Feb 17 2015 | |||
Kirchgraber Paul R | CEO, Covance Drug Development | 7,844 | 1,018,622 | May 10 2021 | 25 months ago | ||
Kong Garheng | Director | 9,438 | 1,225,619 | Feb 08 2021 | |||
Kong Garheng | Director | 2,127 | 276,212 | Feb 12 2015 | |||
Kong Garheng | Director | 624 | 81,033 | Dec 04 2014 | |||
LABORATORY CORP OF AMERICA HOLDINGS | 10% Owner | 119,551,297 | 15,524,931,428 | Sep 07 2016 | |||
LABORATORY CORP OF AMERICA HOLDINGS | 10% Owner | 26,130,959 | 3,393,366,336 | Dec 15 2011 | |||
LAI GOLDMAN MYLA | EVP, Chief Scientific Officer | 52,593 | 6,829,727 | Jun 10 2004 | |||
LAI GOLDMAN MYLA | EVP & Chief Medical Officer | 22,660 | 2,942,628 | May 09 2008 | |||
LAI GOLDMAN MYLA | EVP & Chief Medical Officer | 21,991 | 2,855,751 | Nov 24 2008 | |||
LANE WENDY E | Director | 18,574 | 2,412,020 | Jul 06 2004 | |||
LANE WENDY E | Director | 23,239 | 3,017,817 | May 09 2008 | |||
LANE WENDY E | Director | 18,988 | 2,465,782 | May 12 2014 | |||
MAC MAHON THOMAS P | Chairman of the Board, CEO | 378,480 | 49,149,413 | Jul 06 2004 | |||
MAC MAHON THOMAS P | Director | 106,821 | 13,871,775 | Aug 05 2008 | |||
MAC MAHON THOMAS P | Director | 32,297 | 4,194,088 | Sep 10 2012 | |||
Miller Benjamin R | EVP, Sales & Marketing | 19,927 | 2,587,720 | Mar 28 2008 | |||
MITTELSTAEDT ROBERT E JR | Director | 15,515 | 2,014,778 | May 13 2019 | |||
MITTELSTAEDT ROBERT E JR | Director | 9,408 | 1,221,723 | May 09 2008 | |||
MITTELSTAEDT ROBERT E JR | Director | 10,111 | 1,313,014 | Feb 12 2015 | |||
NEUPERT PETER M | Director | 10,982 | 1,426,123 | Feb 08 2021 | |||
NEUPERT PETER M | Director | 3,671 | 476,716 | Feb 12 2015 | |||
NOVAK RICHARD L | EVP, Chief Operating Officer | 124,657 | 16,187,958 | Apr 23 2004 | |||
NOVAK RICHARD L | EVP, Strategic Planning | 62,270 | 8,086,382 | Mar 08 2006 | |||
Parham Richelle P | Director | 6,074 | 788,770 | Feb 08 2021 | |||
POWELL JAMES B | Director | 13,060 | 1,695,972 | May 05 2004 | |||
Ratliff John D | CEO, Covance Drug Development | 18,025 | 2,340,727 | Apr 05 2019 | |||
Rubenstein Arthur H | Director | 5,679 | 737,475 | May 09 2008 | |||
Rubenstein Arthur H | Director | 11,772 | 1,528,712 | May 12 2014 | |||
Schechter Adam H | President & CEO | 12,316 | 1,599,356 | Feb 08 2021 | |||
Schechter Adam H | Director | 3,237 | 420,357 | Feb 12 2015 | |||
Schroeder Mark S | EVP, President-Diagnostics Lab | 5,006 | 650,079 | Apr 01 2021 | |||
Seltz Judith C | EVP, CHRO | 1,011 | 131,288 | Feb 08 2021 | |||
SMITH BRADFORD T | EVP, Chief Legal Officer, Sec | 97,412 | 12,649,922 | Apr 23 2004 | |||
SMITH BRADFORD T | EVP, Chf Legal Offcr,Secretary | 26,137 | 3,394,151 | May 09 2008 | |||
SMITH BRADFORD T | Director | 16,030 | 2,081,656 | Feb 24 2009 | |||
STARK STEVAN R | Executive Vice President | 49,730 | 6,457,938 | Mar 17 2004 | |||
STARK STEVAN R | Executive Vice President | 81,551 | 10,590,213 | Jan 09 2004 | |||
Summy Amy B. | EVP, Chief Marketing Officer | 266 | 34,543 | Feb 08 2021 | |||
Tanner Deborah L | CEO, Covance Drug Development | 19,754 | 2,565,254 | Mar 15 2016 | |||
Troub Allen W | EVP, Western Operations | 12,697 | 1,648,832 | Mar 05 2007 | |||
Uthgenannt Lisa J | Chief Human Resources Officer | 7,126 | 925,382 | Sep 06 2019 | |||
van der Vaart Sandra D | EVP, Chief Legal Officer | 5,237 | 680,077 | Apr 01 2021 | |||
WALLACE ANDREW G | Director | 11,208 | 1,455,471 | Jul 06 2004 | |||
WALLACE ANDREW G | Director | 11,654 | 1,513,388 | May 03 2007 | |||
Walton Andrew Scott | EVP & CIO | 17,410 | 2,260,863 | May 09 2008 | |||
Walton Andrew Scott | EVP | 22,298 | 2,895,618 | Apr 11 2012 | |||
Watson Craig M | Director | 1,390 | 180,505 | Jul 06 2004 | |||
Watson Craig M | Director | 1,288 | 167,260 | May 13 2005 | |||
WEIKEL M KEITH | Director | 3,196 | 415,033 | Jul 06 2004 | |||
WEIKEL M KEITH | Director | 7,865 | 1,021,349 | May 09 2008 | |||
WEIKEL M KEITH | Director | 13,958 | 1,812,586 | May 09 2014 | |||
Wengel Kathryn E | Director | 0 | 0 | Mar 29 2021 | |||
Wilkinson Peter J | SVP, Chief Accounting Officer | 710 | 92,201 | Feb 19 2021 | |||
Williams R Sanders | Director | 6,232 | 809,288 | Feb 08 2021 | |||
Williams R Sanders | Director | 7,408 | 962,003 | Feb 12 2015 |